Annual EBIT
-$270.83 M
-$42.91 M-18.83%
December 31, 2023
Summary
- As of February 8, 2025, ATRA annual earnings before interest & taxes is -$270.83 million, with the most recent change of -$42.91 million (-18.83%) on December 31, 2023.
- During the last 3 years, ATRA annual EBIT has risen by +$38.23 million (+12.37%).
- ATRA annual EBIT is now -3043.66% below its all-time high of -$8.62 million, reached on December 31, 2013.
Performance
ATRA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.74 M
-$2.96 M-16.62%
September 30, 2024
Summary
- As of February 8, 2025, ATRA quarterly earnings before interest & taxes is -$20.74 million, with the most recent change of -$2.96 million (-16.62%) on September 30, 2024.
- Over the past year, ATRA quarterly EBIT has increased by +$38.52 million (+65.00%).
- ATRA quarterly EBIT is now -211.55% below its all-time high of $18.59 million, reached on June 30, 2022.
Performance
ATRA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$128.37 M
+$47.68 M+27.08%
September 30, 2024
Summary
- As of February 8, 2025, ATRA TTM earnings before interest & taxes is -$128.37 million, with the most recent change of +$47.68 million (+27.08%) on September 30, 2024.
- Over the past year, ATRA TTM EBIT has increased by +$142.46 million (+52.60%).
- ATRA TTM EBIT is now -9881.96% below its all-time high of -$1.29 million, reached on March 31, 2013.
Performance
ATRA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATRA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.8% | +65.0% | +52.6% |
| 3 y3 years | +12.4% | +70.3% | +57.4% |
| 5 y5 years | -14.2% | +70.3% | +57.4% |
ATRA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +20.4% | -211.6% | +77.8% | at high | +63.4% |
| 5 y | 5-year | -18.8% | +20.4% | -211.6% | +77.8% | at high | +63.4% |
| alltime | all time | -3043.7% | +20.4% | -211.6% | +77.8% | -9882.0% | +63.4% |
Atara Biotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.74 M(+16.6%) | -$128.37 M(-27.1%) |
| Jun 2024 | - | -$17.79 M(-41.8%) | -$176.05 M(-22.8%) |
| Mar 2024 | - | -$30.57 M(-48.4%) | -$227.99 M(-15.8%) |
| Dec 2023 | -$270.83 M(+18.8%) | -$59.26 M(-13.4%) | -$270.83 M(-5.3%) |
| Sep 2023 | - | -$68.42 M(-1.9%) | -$286.02 M(-5.2%) |
| Jun 2023 | - | -$69.73 M(-5.0%) | -$301.55 M(+41.4%) |
| Mar 2023 | - | -$73.41 M(-1.4%) | -$213.23 M(-6.4%) |
| Dec 2022 | -$227.92 M(-33.1%) | -$74.45 M(-11.3%) | -$227.92 M(-7.7%) |
| Sep 2022 | - | -$83.96 M(-551.5%) | -$246.87 M(-0.3%) |
| Jun 2022 | - | $18.59 M(-121.1%) | -$247.72 M(-29.3%) |
| Mar 2022 | - | -$88.10 M(-5.7%) | -$350.32 M(+2.9%) |
| Dec 2021 | -$340.46 M(+10.2%) | -$93.40 M(+10.1%) | -$340.46 M(+3.6%) |
| Sep 2021 | - | -$84.81 M(+1.0%) | -$328.76 M(+3.2%) |
| Jun 2021 | - | -$84.00 M(+7.4%) | -$318.65 M(+1.9%) |
| Mar 2021 | - | -$78.25 M(-4.2%) | -$312.60 M(+1.1%) |
| Dec 2020 | -$309.05 M(+4.5%) | -$81.70 M(+9.4%) | -$309.05 M(+0.7%) |
| Sep 2020 | - | -$74.71 M(-4.2%) | -$307.05 M(+0.7%) |
| Jun 2020 | - | -$77.95 M(+4.4%) | -$304.90 M(+0.8%) |
| Mar 2020 | - | -$74.70 M(-6.3%) | -$302.49 M(+2.3%) |
| Dec 2019 | -$295.68 M(+24.7%) | -$79.70 M(+9.8%) | -$295.68 M(-0.7%) |
| Sep 2019 | - | -$72.56 M(-3.9%) | -$297.80 M(+4.3%) |
| Jun 2019 | - | -$75.53 M(+11.3%) | -$285.46 M(+8.7%) |
| Mar 2019 | - | -$67.89 M(-17.0%) | -$262.55 M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$237.11 M(+95.1%) | -$81.82 M(+35.9%) | -$237.11 M(+24.1%) |
| Sep 2018 | - | -$60.22 M(+14.4%) | -$191.10 M(+17.6%) |
| Jun 2018 | - | -$52.62 M(+24.0%) | -$162.54 M(+17.9%) |
| Mar 2018 | - | -$42.45 M(+18.6%) | -$137.82 M(+13.4%) |
| Dec 2017 | -$121.53 M(+49.6%) | -$35.80 M(+13.1%) | -$121.53 M(+16.3%) |
| Sep 2017 | - | -$31.66 M(+13.4%) | -$104.48 M(+5.8%) |
| Jun 2017 | - | -$27.91 M(+6.7%) | -$98.77 M(+9.3%) |
| Mar 2017 | - | -$26.16 M(+39.5%) | -$90.34 M(+11.2%) |
| Dec 2016 | -$81.24 M(+39.0%) | -$18.75 M(-27.7%) | -$81.24 M(-3.6%) |
| Sep 2016 | - | -$25.94 M(+33.1%) | -$84.26 M(+19.4%) |
| Jun 2016 | - | -$19.48 M(+14.2%) | -$70.58 M(+6.6%) |
| Mar 2016 | - | -$17.06 M(-21.6%) | -$66.20 M(+13.3%) |
| Dec 2015 | -$58.45 M(+107.6%) | -$21.77 M(+77.6%) | -$58.45 M(+23.6%) |
| Sep 2015 | - | -$12.26 M(-18.9%) | -$47.27 M(+15.4%) |
| Jun 2015 | - | -$15.11 M(+62.3%) | -$40.96 M(+34.8%) |
| Mar 2015 | - | -$9.31 M(-12.1%) | -$30.39 M(+7.9%) |
| Dec 2014 | -$28.16 M(+226.8%) | -$10.60 M(+78.1%) | -$28.16 M(+34.2%) |
| Sep 2014 | - | -$5.95 M(+31.2%) | -$20.98 M(+19.3%) |
| Jun 2014 | - | -$4.53 M(-35.9%) | -$17.58 M(+22.0%) |
| Mar 2014 | - | -$7.08 M(+107.1%) | -$14.41 M(+67.2%) |
| Dec 2013 | -$8.62 M | -$3.42 M(+33.9%) | -$8.62 M(+65.7%) |
| Sep 2013 | - | -$2.55 M(+87.5%) | -$5.20 M(+96.4%) |
| Jun 2013 | - | -$1.36 M(+5.8%) | -$2.65 M(+105.8%) |
| Mar 2013 | - | -$1.29 M | -$1.29 M |
FAQ
- What is Atara Biotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual EBIT year-on-year change?
- What is Atara Biotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly EBIT year-on-year change?
- What is Atara Biotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM EBIT year-on-year change?
What is Atara Biotherapeutics annual earnings before interest & taxes?
The current annual EBIT of ATRA is -$270.83 M
What is the all time high annual EBIT for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual earnings before interest & taxes is -$8.62 M
What is Atara Biotherapeutics annual EBIT year-on-year change?
Over the past year, ATRA annual earnings before interest & taxes has changed by -$42.91 M (-18.83%)
What is Atara Biotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ATRA is -$20.74 M
What is the all time high quarterly EBIT for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly earnings before interest & taxes is $18.59 M
What is Atara Biotherapeutics quarterly EBIT year-on-year change?
Over the past year, ATRA quarterly earnings before interest & taxes has changed by +$38.52 M (+65.00%)
What is Atara Biotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ATRA is -$128.37 M
What is the all time high TTM EBIT for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM earnings before interest & taxes is -$1.29 M
What is Atara Biotherapeutics TTM EBIT year-on-year change?
Over the past year, ATRA TTM earnings before interest & taxes has changed by +$142.46 M (+52.60%)